Company news
-
Gastric functional serological biopsy marker - PG
PG I and PG II are two important biomarkers that are widely used in clinical settings to diagnose and monitor various gastrointestinal diseases. PG I, also known as pepsinogen I, is mainly secreted by the gastric chief cells and is an indicator of the overall gastric secretory function. On the other hand, PG II, or pepsinogen II, is secreted by both the chief and pyloric cells and is primarily used to assess the risk of gastric cancer.
14-08-2023 -
7 abnormalities in the body, or excessive intestinal "toxins"
If our body shows these seven typical signals, it may be a sign that our intestines are full of toxins.
11-08-2023 -
Intestinal inflammation affects skin health
Intestinal inflammation is closely related to the skin. The gut is one of the largest immune organs in the body and, like the skin, is an external interface in our bodies. There are hundreds of bacteria and other microorganisms in the gut, which make up the gut microbiota and play a vital role in maintaining our immune system, digestion, absorption of nutrients, etc.
09-08-2023 -
Intestinal tumor prevention
The global population of intestinal tumors is very large, with 1.93 million new cases of colon and rectal cancer and 916,000 deaths in 2020, according to statistics from the World Health Organization (WHO). Intestinal tumors have a significant impact on the health and quality of life of people worldwide.
07-08-2023 -
World Hepatitis Day
World Hepatitis Day is observed every year on July 28th to raise awareness towards the viral hepatitis and its prevention. Viral hepatitis is a major global health concern as it affects millions worldwide.
28-07-2023 -
Protecting Yourself from Hepatitis Virus Infection
Hepatitis is a contagious viral infection that affects the liver, causing inflammation and potentially leading to serious health complications. Hepatitis viruses, including Hepatitis A, B, C, D, and E, spread through different modes of transmission. However, by adopting a few preventive measures, we can significantly reduce the risk of hepatitis infection and protect our overall health.
26-07-2023 -
Viral Hepatitis: A Global Threat
Hepatitis refers to the inflammation of the liver, commonly caused by viral infections. Among the various types of viral hepatitis, hepatitis A, B, C, D, and E are the most prevalent. These viruses differ in their modes of transmission, severity, and long-term complications. Viral hepatitis is a significant global health concern, affecting millions worldwide.
24-07-2023 -
An article let you understand: The Diagnostic Kit for Ferritin (fluorescence immunochromatographic assay)
Diagnostic Kit for Ferritin (fluorescence immunochromatographic assay) is a new and innovative tool for measuring iron levels in the body. The test kit is developed by a professional R&D team, and uses advanced fluorescence immunoassay technology to accurately and quickly measure the concentration of ferritin in patients' blood.
21-07-2023 -
Cancer Embryonic Antigen: A New Breakthrough in Cancer Diagnosis
Cancer is one of the most prevalent diseases in the world. It affects millions of people every year and is responsible for countless deaths. Despite the advancements in medical technology, cancer remains a challenging disease to treat. One of the reasons for this is the difficulty in diagnosing cancer early. Now, there is a new hope in cancer diagnosis–the Cancer Embryonic Antigen (CEA).
19-07-2023 -
AFP Test Used in Liver Cancer Screening
In recent years, the screening of alpha-fetoprotein (AFP) for liver cancer has attracted wides attention. AFP is a biomarker for liver cancer. It can help doctors detecting liver cancer earlier and improve treatment success rates by detecting levels of AFP in blood.
17-07-2023